Stockreport

Genelux: An Oncolytic Virus Player About To Cross The Phase 3 Finish Line, But On Shaky Ground [Seeking Alpha]

Genelux Corporation  (GNLX) 
PDF They have had good stewardship of expenses, but they only have around a year of cash remaining, putting them in a potential bind. This, combined with market hype rece [Read more]